News and Announcements
Bioactive Laboratories – On Target For a US Launch Within 24 Months
- Published December 16, 2015 12:22PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Enormous growth has occurred in 2015. Bioactive has brought forward its drug development pipeline by two years after significant infectious disease discoveries were confirmed by the Walter and Eliza Hall Institute of Medical Research. Collaboration and the formation of a new pharmaceutical company have resulted.
On the back of these discoveries Managing Director Rick Ferdinands was invited by Trade Minister Andrew Robb to attend a tropical medicine event where the company is now discussing funding and commercial opportunities with global philanthropic and pharmaceutical companies.
Furthermore, Bioactive’s flagship ‘stomach friendly’ anti-inflammatory is on target for a US launch of its arthritis supplement within 24 months.
With an investor offer open click here to view the latest Wholesale Investor presentation.
ABOUT BIOACTIVE LABORATORIES
Bioactive Laboratories specialises in plant based enhanced extracts. They have developed an anti-microbial that is potent to one of the worlds most deadly & widespread pathogens affecting over 200m people globally in 2012. The magnitude of this discovery has not been seen since the early 1970’s in a plant based treatment for a major infectious disease.
Consequently, Bioactive have forged a collaboration agreement and formed a new pharmaceutical company with the Walter and Eliza Hall institute of Medical Research (WEHI). Financial returns are estimated within 24 months. In addition, Bioactive is steaming ahead with its anti-inflammatory and pain relieving agent that is gentle to the stomach. A US market entry is planned within the next 12 to 18 months, focussing on the US$1.6billion arthritis supplement market.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
